,,ii #aahth ,,congress #ast ,session ,s4 #iic ,,in ,,the ,,senate ,,of ,,the ,,united ,,states ,march #bh1 #bjbc,ms4 ,cortez ,masto 7for herself1 ,mr4 ,grassley1 ,ms4 ,hassan1 ,mr4 ,risch1 ,mrs4 ,shaheen1 ,mrs4 ,capito1 ,mr4 ,marshall1 and ,mr4 ,manchin7 introduced the following bill2 which was read twice and referred to the ,committee on the ,judiciary ,a ,,bill ,to prohibit certain uses of xylazine1 and for other purposes4 #a4 ,short title ,this ,act may be cited as the ,combating ,illicit ,xylazine ,act4 #b4 ,findings ,congress finds the following3 7#a7 ,illicit xylazine presents an urgent threat to public health and safety4 7#b7 ,the proliferation of xylazine as an additive to illicit drugs such as fentanyl and other narcotics threatens to exacerbate the opioid public health emergency4 7#c7 ,there is currently no drug approved by the ,food and ,drug ,administration to reverse the effects of xylazine in humans4 7#d7 ,the physical effects of use of xylazine in humans can include depressed breathing and heart rate1 unconsciousness1 and necrosis1 sometimes leading to amputation or other permanent physical health consequences4 7#e7 ,the spread of illicit xylazine use has followed geographic patterns seen in the spread of recreational fentanyl use1 with proliferation beginning in the ,northeastern ,united ,states and later spreading south and west4 7#f7 ,prompt action to control illicit xylazine will help limit further proliferation of illicit xylazine1 saving countless lives4 #c4 ,definitions 7a7 ,in general ,in this ,act1 the term xylazine has the meaning given the term in paragraph 7#fj7 of section #ajb of the ,controlled ,substances ,act1 as added by subsection 7b7 of this section4 7b7 ,controlled ,substances ,act ,section #ajb of the ,controlled ,substances ,act 7#ba ,u4,s4,c4 #hjb7 is amended-- 7#a7 by redesignating the second paragraph 7#eg7 7relating to serious drug felony7 and paragraph 7#eh7 as paragraphs 7#eh7 and 7#ei71 respectively2 and 7#b7 by adding at the end the following3 7#fj7 ,the term xylazine means any of the following substances1 including their salts1 isomers1 and salts of isomers whenever the existence of such salts1 isomers1 and salts of isomers is possible within the specific chemical designation3 7,a7 ,xylazine4 7,b7 ,xylazine-,m 7#b1f,mich dimethylaniline74 7,c7 ,xylazine-,m 7,n-thiourea-#b1f-;dimethylaniline74 7,d7 ,xylazine-,m 7sulfone-,,ho-7 isomer #b4 7,e7 ,xylazine-,m 7,,ho-#b1f-;dimethylaniline isomer #a74 7,f7 ,xylazine-,m 7,,ho-#b1f-;dimethylaniline isomer #b74 7,g7 ,xylazine ,m 7oxo-74 7,h7 ,xylazine-,m 7,,ho-7 isomer #a4 7,i7 ,xylazine-,m 7,,ho-7 isomer #a glucuronide4 7,j7 ,xylazine-,m 7,,ho-7 isomer #b4 7,k7 ,xylazine-,m 7,,ho-7 isomer #b glucuronide4 7,l7 ,xylazine-,m 7,,ho-oxo-7 isomer #a4 7,m7 ,xylazine-,m 7,,ho-oxo-7 isomer #a glucuronide4 7,n7 ,xylazine-,m 7,,ho-oxo-7 isomer #b4 7,o7 ,xylazine-,m 7,,ho-oxo-7 isomer #b glucuronide4 7,p7 ,xylazine-,m 7sulfone74 7,q7 ,xylazine-,m 7sulfone-,,ho-7 isomer #a4 7,r7 ,any compound1 mixture1 or preparation which contains any quantity of any of the substances referred to in subparagraphs 7,a7 through 7,q74 4 #d4 ,unlawful distribution and penalties relating to xylazine 7a7 ,prohibited ,acts ,a--,penalties 7#a7 ,controlled ,substances ,act ,section #dja of the ,controlled ,substances ,act 7#ba ,u4,s4,c4 #hda7 is amended-- 7,a7 in subsection 7a77#a71 by inserting or xylazine for illicit uses under section #dbd after controlled substance2 and 7,b7 in subsection 7b77#a77;,e77i71 by inserting or unlawful distribution of xylazine for illicit uses under section #dbd after schedule ,,iii4 7#b7 ,controlled ,substances ,import and ,export ,act ,section #ajaj of the ,controlled ,substances ,import and ,export ,act 7#ba ,u4,s4,c4 #ifj7 is amended-- 7,a7 in subsection 7a7-- 7i7 in paragraph 7#a71 by inserting or xylazine for illicit uses under section #dbd after controlled substance2 7ii7 in paragraph 7#b71 by inserting or xylazine for illicit uses under section #dbd after controlled substance2 and 7iii7 in paragraph 7#c71 by inserting or xylazine for illicit uses under section #dbd after controlled substance2 and 7,b7 in subsection 7b77#e71 by inserting or the unlawful distribution of xylazine for illicit uses under section #dbd after schedule ,,iii4 7b7 ,illicit use and distribution ,part ,d of the ,controlled ,substances ,act 7#ba ,u4,s4,c4 #dja et seq47 is amended by adding at the end the following3 #dbd4 ,illicit use and distribution of xylazine 7a7 ,illicit use ,it is unlawful for any person to engage in any of the following illicit uses of xylazine3 7#a7 ,any use in the human species4 7#b7 ,any use that is not a licit use4 7b7 ,licit use ,licit use of xylazine means-- 7#a7 any administration to nonhuman species-- 7,a7 of a drug containing xylazine that has been approved by the ,secretary of ,health and ,human ,services under section #eab of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cfj;b72 or 7,b7 that is permissible under section #eab7;a77#d7 of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cfj;b7a77#d772 7#b7 the manufacturing1 importation1 or use of xylazine as an active pharmaceutical ingredient for manufacturing an animal drug approved under section #eab of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cfj;b7 or issued an investigation use exemption under subsection 7j7 of such section #eab2 7#c7 the manufacturing1 importation1 or use of a xylazine bulk chemical for pharmaceutical compounding by licensed pharmacists or veterinarians2 or 7#d7 another use approved or permissible under the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cja et seq474 4 #e4 ,arcos tracking ,section #cjg7;i7 of the ,controlled ,substances ,act 7#ba ,u4,s4,c4 #hbg7 is amended-- 7#a7 in the matter preceding paragraph 7#a7-- 7,a7 by inserting or xylazine after gamma hydroxybutyric acid2 7,b7 by inserting or #eab after section #eje2 and 7,c7 by inserting respectively1 after the ,federal ,food1 ,drug1 and ,cosmetic ,act12 and 7#b7 in paragraph 7#f71 by inserting or xylazine after gamma hydroxybutyric acid4 #f4 ,report to ,congress on xylazine 7a7 ,initial report ,not later than #a year after the date of the enactment of this ,act1 the ,attorney ,general1 acting through the ,administrator of the ,drug ,enforcement ,administration and in coordination with the ,commissioner of ,food and ,drugs1 shall submit to ,congress a report on the prevalence of illicit use of xylazine in the ,united ,states and the impacts of such use1 including-- 7#a7 where the drug is being diverted2 7#b7 where the drug is originating2 7#c7 whether any analogues to such drug present a substantial risk of abuse2 7#d7 whether and to what extent the illicit supply of xylazine derives from the licit supply chain2 and 7#e7 recommendations for ,congress with respect to whether xylazine should be transferred to another schedule under part ,b of the ,controlled ,substances ,act 7#ba ,u4,s4,c4 #haa et seq474 7b7 ,additional report ,not later than #d years after the date of the enactment of this ,act1 the ,attorney ,general1 acting through the ,administrator of the ,drug ,enforcement ,administration and in coordination with the ,commissioner of ,food and ,drugs1 shall submit to ,congress a report updating ,congress on the prevalence of xylazine trafficking1 misuse1 and proliferation in the ,united ,states1 including recommendations for ,congress with respect to whether xylazine should be transferred to another schedule under part ,b of the ,controlled ,substances ,act 7#ba ,u4,s4,c4 #haa et seq47 or removed from schedule ,,iii of such part4 7c7 ,definition ,in this section1 the term illicit use means any use described in section #dbd of the ,controlled ,substances ,act1 as added by section #c of this ,act4 #g4 ,declaration of emerging threat ,congress declares illicit xylazine use an emerging drug threat1 as defined in section #gjb of the ,office of ,national ,drug ,control ,policy ,reauthorization ,act of #aiih 7#ba ,u4,s4,c4 #agja71 in the ,united ,states4